• Mashup Score: 2

    Background There is a clear need for novel approaches to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage vaccine and test its safety, infectivity, and immunogenicity in healthy volunteers. Our approach was to target the gene encoding the knob-associated histidine-rich protein (KAHRP), which is responsible for the assembly of knob structures at the infected…

    Tweet Tweets with this article
    • A new study led by Dr. James McCarthy at @QIMRBerghofer represents the first clinical investigation of a genetically attenuated blood-stage human #MalariaVaccine. 💉 @BMCMedicine | https://t.co/0y1rsAmnPo https://t.co/9VTpmQrC02